BioSpace News Archive

DiaMedica Therapeutics Inc. today announced the company will be attending the 2023 AAN Summer Conference on July 28-29, at the Minneapolis Hyatt Regency.

Monogram Orthopaedics Inc., today announced the Company executed a conditional purchase order to initiate a pilot program with a global distributor.

Neurophet announced its participation in the Alzheimer’s Association International Conference (AAIC) 2023, which is held in Amsterdam, Netherlands.

Covalon Technologies Ltd. announced the publication of an article in the Journal of the Association for Vascular Access, titled “Guarding the Central Venous Access Device: A New Solution for an Old Problem”, authored by Darcy Doellman, MSN, RN, VA-BC, a leading expert in pediatric vascular access.

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2023 after the market close on Tuesday, August 1, 2023.

LianBio announced that partner Nanobiotix has entered into a license agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the investigational, potential first-in-class radioenhancer NBTXR3.

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced participation on a panel during the 2023 American Society of Pharmacognosy (ASP) Annual Meeting.

Kaléo announced their selection by the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical to develop a reconstitution auto-injector device that delivers atropine, the Reconstitution Auto-Injector Device – Atropine.

Renibus Therapeutics, Inc. today announced raising $47 million from the initial closings of a Series B financing.

Duoning Biotechnology Co., Ltd. has used Shanghai Duoning Yuexi Biological Technology Co., Ltd. to sign an agreement to acquire Changzhou PreFluid Technology Co., Ltd., a professional manufacturer of peristaltic pumps, expanding its key product portfolio related to fluid transport and upgrading the fluid management solutions.